Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q3
$176K Sell
3,717
-307
-8% -$15.6K 0.01% 1265
2015
Q2
$199K Buy
4,024
+256
+7% +$13K 0.01% 1251
2015
Q1
$186K Buy
3,768
+124
+3% +$5.93K 0.01% 1280
2014
Q4
$166K Buy
3,644
+762
+26% +$37K 0.01% 1306
2014
Q3
$163K Sell
2,882
-139
-5% -$7.47K 0.01% 1261
2014
Q2
$161K Sell
3,021
-179
-6% -$9.5K 0.01% 1275
2014
Q1
$167K Buy
3,200
+109
+4% +$5.52K 0.01% 1189
2013
Q4
$166K Buy
3,091
+34
+1% +$1.75K 0.01% 1178
2013
Q3
$155K Sell
3,057
-103
-3% -$5.24K 0.01% 1126
2013
Q2
$163K Buy
+3,160
New +$168K 0.02% 994

Other funds holding SNY

OFI Advisors's SNY Position: Q3 2015 in Review

OFI Advisors reduced its Sanofi (SNY) stake by 7.6% in Q3 2015, selling an estimated $15.6K and leaving 3,717 shares worth $176K. The position accounts for 0.01% of the portfolio, ranked #1265.

OFI Advisors first reported a position in SNY in Q2 2013 and has held it in 10 quarters since. The position peaked at $199K in Q2 2015. 500 funds tracked by Wall St. Rank hold SNY as of Q3 2015.

  • OFI Advisors held 3,717 shares of Sanofi worth $176K as of Q3 2015.
  • OFI Advisors sold 307 Sanofi shares in Q3 2015, an estimated $15.6K.
  • Sanofi made up 0.01% of OFI Advisors's portfolio in Q3 2015, its #1265 holding.
  • OFI Advisors first reported a position in Sanofi in Q2 2013 and has held it in 10 quarters since.
  • OFI Advisors's Sanofi position peaked at $199K in Q2 2015.
  • 500 funds tracked by Wall St. Rank held Sanofi as of Q3 2015.

Based on OFI Advisors's 13F filing for Q3 2015, filed 13 Nov 2015.